Achieve Life Sciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $37.3M | $35.9M |
| FY2021 | — | $28.0M | $43.0M |
| FY2022 | — | $8.3M | $24.8M |
| FY2023 | — | $-1.4M | $15.5M |
| FY2024 | — | $20.9M | $12.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $37.3M | $35.9M |
| FY2021 | — | $28.0M | $43.0M |
| FY2022 | — | $8.3M | $24.8M |
| FY2023 | — | $-1.4M | $15.5M |
| FY2024 | — | $20.9M | $12.8M |